Glycodelin contains four isoforms with diverse biological functions. Glycodelin-A is 2 potential diagnostic marker for cancer patients and receptive marker of secretory 3 endometrium. Yet, direct evidence of glycodelin on regulating endometrial epithelial cells 4 migration, invasion and attachment of trophoblastic spheroids (blastocyst surrogate) is 5 lacking. In this study, the human glycodelin gene was stably transfected into the human 6 endometrial (HEC1-B) cells. Forced-expression of glycodelin in HEC1-B cells did not 7 affect cell proliferation, cell viability and cell cycle progression, but significantly reduced 8 migration and invasion of the stably transfected cells. The migration rate returned to 9 normal levels when the glycodelin stably expressing HEC1-B cells were treated with 10 glycodelin RNAi. Furthermore, forced-expression of glycodelin in HEC1-B cells 11 significantly increased the attachment of trophoblastic spheroids onto the endometrial 12 epithelial cells. In sum, glycodelin suppressed endometrial cell migration/invasion but 13 enhanced spheroids attachment. 14 15
INTRODUCTION 1
The lipocalin subfamily member glycodelin has several isoforms found in the reproductive 2 system, namely glycodelin-A (GdA), glycodelin-F (GdF), glycodelin-S (GdS), and Glycodelin-A, a progesterone-regulated glycoprotein, is highly expressed during the 12 secretory phase in the human endometrium (Seppala et al., 2002) . The level of GdA 13 gradually increases in the endometrial glands 4 to 5 days after ovulation and reaches its 14 have compared gene expression patterns of the endometrium during the menstrual cycle 1 (Carson et al., 2002; Talbi et al., 2006) . A large number of genes showed cyclical variation 2 in expression, but only a few genes including osteopontin, apolipoprotein D, 3 dickkopf/DKK1 and olfactomedin were found to be common in all these studies 4 (Horcajadas et al., 2004) . Abnormal levels of glycodelin are associated with unexplained 5 infertility and early pregnancy loss (Seppala et al., 2009). 6
Glycodelin is also involved in the progression of gynecological cancers. An aberrant 7 expression of glycodelin is associated with endometrial, ovarian and breast cancers 8 0.5% sodium deoxycholate, 0.1 % SDS) containing protease inhibitors. The samples were 10 separated on 12% SDS-PAGE and the proteins were transferred to a PVDF membrane. 11
After thorough washing, the membrane was probed with glycodelin antibody (rabbit 12 antibody raised against glycodelin peptide, amino acids 69-83) at 1:1000 dilution, α-13 tubulin (1:5000, Santa Cruz, Santa Cruz, CA, USA) and β-actin antibody (1:5000, Sigma). 14 Positive signal was detected by chemiluminescence using goat anti-rabbit or goat anti-15 mouse IgG conjugated-HRP secondary antibodies. 16 17
Flow cytometry 18
Transfected HEC1-B cells were collected and fixed in 70 % ethanol. The cells were 19 washed in phosphate buffered saline twice and stained with 2.5 µg/ml propidium iodide. 20
DNA content was measured by flow cytometry on a BD FACSCantoII Analyzer (BD 21
Biosciences, San Jose, CA, USA) equipped with a 488 nm argon laser. Fluorescence 22 signals were measured using a 585 nm band pass filter. The results were analyzed using 23
WinMDI 2.9 (The Scripps Research Institute Cytometry Software, San Diego, CA, USA) 24
and Cylchred (Cytonet UK, Cardiff, UK). 25
26

Cell Migration Assay 1
The migration rate of glycodelin overexpressing HEC1-B cells was determined in a wound 2 healing assay. Briefly, 2 x 10 5 HEC1-B cells in 2 ml MEM medium on 6-well plates were 3 grown overnight at 37 °C. The cells were treated with 20 µg/ml mitomycin C (Sigma) for 3 4 h. The culture medium was changed and a wound was created on each well using the tip of 5 a pipette. The migration rate was expressed as a percentage of the width of the wound at 48 6 h divided by the width of the wound at 0 h. 7 8
Cell Invasion Assay 9
The cell invasion of the transfected HEC1-B cells was studied using a BD Biocoat™ 10
Matrigel™ Invasion Chamber (BD Biosciences). The invasion chambers used a 9 µm pore 11 size polyethylene terephthalate membrane, which was chosen for this study because it 12 could effectively block non-invasive cells from migrating through the membrane while 13
allowing invasive cells to pass through. The HEC1-B cells (5 x 10 4 cells/ml in 0.5 ml 14 serum-free MEM medium) were seeded on the invasion chamber and incubated at 37 °C 15 for 24 h. The empty vector clone was used as the control. Non-invading cells were 16 removed from the interior chamber by scrubbing with a cotton swab. The invading cells on 17 the bottom of the membrane were stained with crystal violet stain for 25 min. 18
19
RNAi transfection 20
RNAi targeted against glycodelin (Human LOC649984, Thermo Fisher Scientific, 21
Lafayette, CO, USA) was diluted to 10 nmol and transfected into glycodelin Mann-Whitney U test was used when the data were not normally distributed. A probability 15 value <0.05 was considered to be statistically significant. 16
RESULTS
1
Forced-expression of glycodelin on cell growth 2
The cDNA coding region of glycodelin was cloned into the pHM6 mammalian expression 3 vector and transfected into HEC1-B cells. Gentamycin was used to select glycodelin 4 forced-expressing clones (4-1 and 4-2), and the empty vector transfected control clone (1-5 5). Western blotting results confirmed the expression of glycodelin protein in clones 4-1 6 and 4-2, but not in clone 1-5 ( Fig. 1A) . Quantitative PCR results confirmed that the 7 expression levels of glycodelin transcript in clones 4-1 and 4-2 were 10 5 -fold higher than 8 in clone 1-5 ( Fig. 1A) . Forced-expression of glycodelin had no effect on cell proliferation 9
and cell viability in all the selected clones (data not shown). 10
Flow cytometry was used to monitor the DNA content of stably transfected cells at 11 different phases of the cell cycle. We analyzed the 2N (G0/G1 phase) and 4N (G2/M 12 phase) DNA content. No changes were observed in the percentages of cells in G0/G1, S 13 and G2/M phases in all the selected clones (Fig. 1B) . This result was confirmed by qPCR 14 of the cell cycle checkpoint transcripts including p16, p21 and p27 (data not shown). 15
16
Forced-expression of glycodelin on cell migration and invasion 17
Cells in the wound healing assay were treated with mitomycin C to suppress cell 18 proliferation. Therefore, the change in area covered by cells was only caused by cell 19 migration, but not division and proliferation. Forced-expression of glycodelin in HEC1-B 20 cells in clones 4-1 and 4-2 suppressed the migration of the transfected HEC1-B cells when 21 compared with the control clone 1-5 ( Fig. 2A ). The migration rates in clones 4-1 and 4-2 22
were significantly lower (23% and 35%, respectively; p<0.05) than in control clone 1-5 23 (51%). The effect of glycodelin on cell invasion was studied using a cell invasion chamber 24 assay. The cell invasion of clones 4-1 and 4-2 was significantly decreased (30% each; 25 p<0.05) compared with the control clone 1-5 ( Fig. 2B) . 26 1
Suppression of glycodelin in stably transfected cells increases cell migration 2
RNAi knockdown of the glycodelin expression in the stably transfected clones was 3 performed to confirm the effect of glycodelin on cell migration. The expression of 4 glycodelin protein in clone 4-1 was found to be down-regulated by glycodelin RNAi 5 compared with the control clone 1-5 (>50% reduction) (Fig. 2C ). Transfection of 6 glycodelin RNAi did not affect migration in the control clone 1-4, but significantly 7 increased the migration rate (43%) in clone 4-1 (Fig. 2C) . No changes in migration rate 8
were observed when the cells were treated with non-target RNAi. 9
10
Effect of glycodelin forced-expression on spheroid attachment 11
Forced-expression of glycodelin in HEC1-B cells increased the rate of attachment of 12 trophoblastic spheroids onto the endometrial epithelial cells (Fig. 3A) . The rate of 13 attachment of spheroids on glycodelin forced-expressing clones 4-1 and 4-2 was 14 significantly higher (84% and 89%, respectively; p<0.05) than on control clone 1-5 (72%) 15 (Fig. 3B) . 16
DISCUSSION 1
Previous studies showed that GdA inhibits NK cell activity, monocyte chemotaxis, T and B 2 cell proliferation, and induces apoptosis in monocytes (Alok and Karande, 2009 ). In the 3 present study, forced-expression of glycodelin in the HEC1-B cells did not significantly 4 affect the cell cycle progression as confirmed by the cell proliferation assay, qPCR, and 5 flow-cytometry analysis. 6
Glycodelin has been found in breast cancer tissues and was detected in 50% of lymph 7 node metastases, 38% of recurrent breast cancers, and 40% of breast cancers with distant 8 metastases (Jeschke et al., 2005) . Chemotherapy-treated ovarian cancer patients with 9
higher glycodelin expression had longer survival times and less metastases than those with 10 glycodelin-negative ovarian cancers at the same stages and differentiation grades 11 glycodelin is responsible for number of pathways which affects steroid receptivity, growth 8 and invasive potential in endometriotic tissues (Koistinen et al., 2005; Gaetje et al., 1995) . 9
In the current study, increase in glycodelin expression could reduce migratory and invasive 10 property of endometrial epithelial cells, which might cause a reduction in endometriosis. 11
Therefore, increase in glycodelin expression might contribute to advantage for successful 12 implantation and pregnancy in an indirect way by minimizing the effect of endometriosis 13
and up-regulation of receptive marker (Uchida et al., 2007) . 
